USPTO serial 79041967
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Transdermal patches for use in the treatment of allergy, vaccination, transcutaneous drug delivery and cosmetics through cutaneous or epicutaneous administration means of powdered medical or pharmaceutical substances for human or animal purposes, Transdermal patches containing a preparation in powder form for medical use in the treatment of allergy, vaccination, transcutaneous drug delivery and cosmetics; transdermal occlusive patch for cutaneous absorption of a powdered medicated substance for use in the treatment of allergy, vaccination, transcutaneous drug delivery and cosmetics; Transdermal patches for vaccine administration; Transdermal patches for cosmaceutical epidermal therapies; Transdermal patches for use in the treatment, prevention, or diagnosis of allergies, Transdermal patches for use in dermatology; Transdermal patches for use in oncology; Transdermal patches containing medicine | SECTION 70 - CANCELLED | — |
| 010 | Transdermal drug delivery patches sold without medication; Medical apparatus and instruments for cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for use in diagnosing allergies; Medical apparatus and instruments for cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for use in vaccine administration; Medical apparatus and instruments for cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for use in cosmaceutical epidermal therapies; Medical apparatus and instruments for use in cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for use in dermatology and oncology treatments; Medical apparatus and instruments for cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for medical use | SECTION 70 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 16, 2017 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Dec 15, 2017 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Feb 17, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 12, 2013 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 18, 2009 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 18, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 18, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 5, 2009 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 19, 2009 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 19, 2009 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 18, 2008 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 18, 2008 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 16, 2008 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 16, 2008 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 16, 2008 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 24, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 24, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 24, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 24, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 24, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 24, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 22, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 21, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 14, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Sep 13, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |